Elevated levels of circulating soluble ST2 at discharge predict late adverse ventricular remodeling in patients with ST-segment elevation myocardial infarction. Biomed. Res. Ther. 2018;5(12):2863-2875. doi:10.15419/bmrat.v5i12.505